ロード中...
Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway
PURPOSE: The options for treating lung cancers are limited, as diagnosis typically occurs during the late stages of the disease. There is a dire need to develop aPKC (atypical Protein Kinase C) inhibitors due to aPKC overexpression and contributions to lung cancer malignancies. In this study, we inv...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7047975/ https://ncbi.nlm.nih.gov/pubmed/32158232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S224866 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|